Skip to main content

Table 6 Characteristics of patients with failure

From: Comparison of accelerated partial breast irradiation via multicatheter interstitial brachytherapy versus whole breast radiation

Age at Diagnosis Menopause Status ASTRO Category Size Histology Grade Biomarker Pattern Node Biopsy Adjuvant Treatment Radiation Modality Initial Failure Failure (months) Salvage Treatment Current Status
61.7 Post cautionary 1.00 DCIS II +/-/? No R + E APBI Local - E 20.3 MRM + C + E NED
62.1 Post acceptable 0.30 IDC I +/+/- Yes R + E APBI Local - T 45.3 MRM + C NED
66.8 Post acceptable 1.00 IDC II +/+/- Yes R + E APBI Local - E 59.6 SM NED
69.3 Post acceptable 2.00 IDC II +/-/- Yes R + E APBI Local - E 38.2 PM + C + WBI + E NED
59.5 Post cautionary 2.00 IDC II +/-/- Yes R + E + C APBI Local - E 47.1 MRM + C + E NED
68.2 Post cautionary 0.90 IDC III -/-/- Yes R WBI Local - E 49.5 MRM NED
57.0 Post cautionary 1.50 IDC III -/-/- Yes R + C WBI Local - T 5.2 SM NED
56.5 Post cautionary 0.90 DCIS III +/+/? No R WBI Local - T 49.3 SM NED
62.3 Post acceptable 0.60 IDC II +/+/- Yes R + E WBI Local - E 97.5 MRM + E NED
45.4 Pre unsuitable 3.00 IDC II +/+/- Yes R + E + C APBI Regional 55.0 SR + C Expired
53.6 Post cautionary 3.00 IDC II +/+/- Yes R + E APBI Regional 17.1 SR + C + R NED
70.7 Post cautionary 0.80 IDC III -/-/- Yes R APBI Metastatic 32.4 C + H Expired
68.6 Post cautionary 1.00 IDC III +/+/- Yes R WBI Metastatic 13.2 - Expired
71.1 Post cautionary 2.10 IDC III -/-/+ Yes R + C APBI Metastatic 45.4 C + R Under Treatment
56.5 Post cautionary 2.90 IDC III +/+/+ Yes R + C + E APBI Metastatic 60.8 R Under Treatment
58.1 Post cautionary 1.50 IDC II +/-/- Yes R WBI Metastatic 46.1 C Under Treatment
  1. Abbreviations: SM simple mastectomy, MRM modified radical mastectomy, PM partial mastectomy, R radiotherapy, C chemotherapy, E endocrine therapy, H Herceptin, Local-T - true recurrence, Local-E - elsewhere recurrence. Biomarker pattern shows the status for estrogen receptor, progesterone receptor, and HER2/neu using the following symbolic code: (ER)/(PR)/(HER2/neu). Presence of the biomarker is indicated by '+,' absence by '-,' unknown by '?.'